Mark P. Frissora
Director · BIOADAPTIVES, INC.
IndividualBuying only
- 2025
- Oct 6, 2026
- 19
Other insiders active in the same sector
No other insider has filed at Mark P. Frissora's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- J.H. Whitney Equity Partners VII, LLC - $319.15M in AVAH purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark P. Frissora?
Mark P. Frissora is a corporate insider, tracked as Director of BIOADAPTIVES, INC. (BDPT). InsiderAlpha holds 19 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark P. Frissora submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Mark P. Frissora been buying or selling stock?
Recorded transactions: 2 open-market purchases ($300K) and 0 open-market sales across all tracked filings.
